BMFPs, a versatile therapeutic tool for redirecting a preexisting Epstein-Barr virus antibody response toward defined target cells.

IgG binding to the Nb-αDARC-P18F4 was noticeably lower, although the differences with αDARC-P18F2 and Nb-αDARC-P18F3 did not reach statistical significance ( Fig. 2H , right).

also in 111,027 other papers